Literature DB >> 18781621

Modified chitosans for oral drug delivery.

Martin Werle1, Hirofumi Takeuchi, Andreas Bernkop-Schnürch.   

Abstract

The cationic polysaccharide chitosan has been extensively studied for oral drug delivery. In recent years, chemically modified chitosans developed in order to improve the properties of chitosan for oral drug delivery have gained increasing attention. Representatives of these novel polymers are trimethyl-chitosans, thiolated chitosans, carboxymethyl chitosan and derivatives, hydrophobic chitosans, chitosan succinate and phthalate, PEGylated chitosans and chitosan-enzyme inhibitor conjugates. Besides their use for oral delivery of therapeutic peptides and proteins, they have recently been evaluated regarding their potential for the delivery of other substance classes, including genes and efflux pump substrates. Within the current review, various modified chitosan derivatives, their properties and synthesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18781621     DOI: 10.1002/jps.21550

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

2.  Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes.

Authors:  Anshuman Shukla; Bhupinder Singh; O P Katare
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.

Authors:  Shu Wang; Rui Su; Shufang Nie; Ming Sun; Jia Zhang; Dayong Wu; Naima Moustaid-Moussa
Journal:  J Nutr Biochem       Date:  2013-11-05       Impact factor: 6.048

4.  Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.

Authors:  Reza Mahjub; Farid Abedin Dorkoosh; Mohsen Amini; Mohammad Reza Khoshayand; Morteza Rafiee-Tehrani
Journal:  AAPS PharmSciTech       Date:  2011-10-27       Impact factor: 3.246

Review 5.  Advanced drug delivery systems of curcumin for cancer chemoprevention.

Authors:  Shyam S Bansal; Mehak Goel; Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-05

6.  Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.

Authors:  Maryam Mansourpour; Reza Mahjub; Mohsen Amini; Seyed Naser Ostad; Elnaz Sadat Shamsa; Morteza Rafiee-Tehrani; Farid Abedin Dorkoosh
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

7.  Chitosan-Coated Liposomes: The Strategy to Reduce Intestinal Toxicity and Improve Bioavailability of Oral Vinorelbine.

Authors:  Chen Guo; Xichun Zhu; Haoyang Yuan; Haoyu Liu; Yu Zhang; Tian Yin; Haibing He; Jingxin Gou; Xing Tang
Journal:  AAPS PharmSciTech       Date:  2022-06-10       Impact factor: 3.246

Review 8.  Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers.

Authors:  Riccardo A A Muzzarelli
Journal:  Mar Drugs       Date:  2010-02-21       Impact factor: 5.118

9.  Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.

Authors:  Maria Manconi; Amparo Nácher; Virginia Merino; Matilde Merino-Sanjuan; Maria Letizia Manca; Carla Mura; Simona Mura; Anna Maria Fadda; Octavio Diez-Sales
Journal:  AAPS PharmSciTech       Date:  2013-03-08       Impact factor: 3.246

10.  Fabrication and Characterization of Thiolated Chitosan Microneedle Patch for Transdermal Delivery of Tacrolimus.

Authors:  Zulcaif Ahmad; Muhammad Imran Khan; Muhammad Irfan Siddique; Hafiz Shoaib Sarwar; Gul Shahnaz; Syed Zajif Hussain; Nadeem Irfan Bukhari; Irshad Hussain; Muhammad Farhan Sohail
Journal:  AAPS PharmSciTech       Date:  2020-01-16       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.